These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [The birth of new drugs]. Petrányi G Orv Hetil; 1968 May; 109(21):Suppl:1-6. PubMed ID: 5720715 [No Abstract] [Full Text] [Related]
3. [Guidelines for introducing new drugs for medical use in Poland and control of their quality]. Danysz A Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321 [No Abstract] [Full Text] [Related]
4. [Harmful effects of drugs. Liability of the manufacturers against insurance claims for damages]. Dahl B Ugeskr Laeger; 1984 Sep; 146(36):2726-8. PubMed ID: 6515894 [No Abstract] [Full Text] [Related]
5. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products. Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700 [No Abstract] [Full Text] [Related]
7. [Standards imposed by the pharmacopoeia on drugs]. Büchi J Pharm Acta Helv; 1972; 47(11):648-63. PubMed ID: 4657534 [No Abstract] [Full Text] [Related]
8. QUAD routes out inferior drugs. Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804 [No Abstract] [Full Text] [Related]
9. Extra-label drug use--pharmaceutical industry view. Welser JR J Am Vet Med Assoc; 1993 May; 202(10):1635-42;discussion 1654-8. PubMed ID: 8514571 [No Abstract] [Full Text] [Related]
10. [Standardization as a basis planning and administration in drug industry and pharmacy (II)]. Wagler M Pharm Prax; 1970; 7():151-3. PubMed ID: 5469874 [No Abstract] [Full Text] [Related]
12. Toward more effective drug regulation. Schmidt AM FDA Consum; 1975 Dec-1976 Jan; 9(10):27-9. PubMed ID: 10316532 [No Abstract] [Full Text] [Related]
13. [The new norms decreed by the legislative dirrective 91-93 CCE]. Neri M; Palazzo S Boll Chim Farm; 1998 Feb; 137(2):31-4. PubMed ID: 9595832 [TBL] [Abstract][Full Text] [Related]
14. Negotiating reality: the construction of enforceable pharmaceutical standards. Parrish RH Food Drug Law J; 2002; 57(3):457-74. PubMed ID: 12710406 [No Abstract] [Full Text] [Related]
15. [Responsibility for drug testing and control]. Büchi J Pharm Acta Helv; 1968 Sep; 43(9):619-27. PubMed ID: 5718866 [No Abstract] [Full Text] [Related]
16. The Food and Drug Administration's over-the-counter drug review: why review OTC drugs? Moxley JH; Yingling GL; Edwards CC Fed Proc; 1973 Apr; 32(4):1435-7. PubMed ID: 4701750 [No Abstract] [Full Text] [Related]
17. Achieving a quality drug supply. Nelson G J Am Pharm Assoc; 1974 Oct; 14(10):548-9, 564. PubMed ID: 4420394 [No Abstract] [Full Text] [Related]